When compared to the NAFLD group, only the expression level of CYP7A1 in the liver tissues of the BL group mice significantly increased (p < .05), with no significant changes observed in the expression levels of FXR and FGF‐15 (Figure 2D–F). The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatotic liver disease.